In vitro release kinetics and bio availability of oral controlled release layered matrix tablets of diltiazem hydrochloride

International Journal of Drug Development and Research

Volumn 3, Issue 1, 2011, Pages 234-241

  Syed, Izhar Ahmed ^a   Narsu, M Lakshmi ^b   Rao, Y Madhusudan ^c  

^a Pathfinder Institute of Pharmacy Education and Research   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^c University College of Pharmaceutical Sciences   (India)

Author keywords

Controlled released; Diltiazem HCL; Matrix and layered matrix tablets

Indexed keywords

DILTIAZEM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DIFFUSION; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MATRIX TABLET; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; TABLET COMPRESSION;

EID: 79955918817     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Colombo P, Conte U, Gazzaniga A, Maggi L, Sangalli M. E, Peppas N. A, La Manna A, Drug release modulation by physical restrictions of matrix swelling. Int. J. Pharm,1990; 63: 43-48.
2. Conte U, Maggi L, Colombo P, La Manna A, Multi-layered hydrophilic matrices as constant release devices. J. Cont. Rel, 1993; 26: 39-47.
3. Conte U, Colombo P, Maggi L, La Manna A, Compressed barrier layers for constant drug release in swell able matrix tablets. STP Pharma Sci, 1994; 4: 107-113.
4. Yihong Qui, Koplette F. Design of sustained release matrix system for a highly water soluble compound. ABT-089. Int J Pharm, 1997;157: 46-52.
5. Conte U, Maggi L, Torre ML, Giunchedi P, Manna La A. Press-coated tablets for time-programmed release of drugs. Biomaterials, 1993; 14: 1017-1023.
6. Prisant L.M and W.J Elliot, Drug Delivery Systems for treatment of systemic Hypertension, Clin Pharmacokinet 2003; 42 (11): 931-940.
7. Altaf SA, Parasrampuria Yu K, Friend JDR. Guar gum based sustained release diltiazem. Pharm Res. 1998; 15: 1196-1201.
8. Gohel M.C., Panchal MK. Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design. Drug Dev. Ind. Pharm. 2002; 28(1): 77-87.
9. st ed. Marcel Decker Inc, New York 1992; pp191-194.
10. Al-Saidan, SM. Krishnaiah YS.R, Patro SS, Satyanaryana V. In Vitro and In Vivo Evaluation of Guar Gum Matrix Tablets for Oral Controlled Release of Water-soluble Diltiazem Hydrochloride. AAPS Pharm SciTech, 2005; 6 (1) E14-E21
11. Langenbucher F, Möller H, Correlation of in vitro drug release with in vivo response kinetics, Pharm. Ind. 1983; 45 (6), 623-628.